Longeveron

company

About

Longeveron is a life-sciences company that develops biological solutions for aging and aging-associated diseases.

  • 1 - 10

Details

Last Funding Type
Grant
Last Funding Money Raised
$3.80M
Industries
Biotechnology,Life Science,Medical
Founded date
Jan 1, 2014
Number Of Employee
1 - 10
Operating Status
Active

Longeveron is a life-sciences company that develops biological solutions for aging and aging-associated diseases. This is through the testing of allogeneic human Mesenchymal Stem Cells (MSCs) that are derived from the bone marrow of young, healthy donors. The Longeveron-grown Mesenchymal Stem Cell (LMSCs) product is manufactured in Longeveron’s cell processing facility located in Miami, Florida.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$4.55M
Longeveron has raised a total of $4.55M in funding over 2 rounds. Their latest funding was raised on Oct 18, 2018 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Oct 18, 2018 Grant $3.80M 1 National Institutes of Health Detail
May 22, 2018 Grant $750K 1 TEDCO Detail

Investors

Number of Lead Investors
Number of Investors
2
2
Longeveron is funded by 2 investors. National Institutes of Health and TEDCO are the most recent investors.
Investor Name Lead Investor Funding Round
National Institutes of Health Yes Grant
TEDCO Yes Grant